Supernus Pharmaceuticals (Nasdaq: SUPN) filed an initial public offering to raise up to $100 million in common stock. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE